This inventor holds 2 USPTO granted patents. Top assignee: Agency of Industrial Science and Technology. Active years: 1996-1998.
Company Filing History:
Years Active: 1996-1998
Title: Hiroaki Okuno: Innovator in Anticancer Agents
Introduction
Hiroaki Okuno is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer agents. With a total of 2 patents to his name, Okuno's work focuses on innovative compounds that target cancer cells effectively.
Latest Patents
Okuno's latest patents include groundbreaking work on stereospecific 5-fu esters and esters of p-hydroxyaniline mustard. The first patent discloses an ester compound that is resistant to decomposition in blood but is quickly hydrolyzed in cancer cells, functioning as an effective anticancer agent. The compound's structure is represented by specific formulas, where R₁ can be a methyl group, a methoxy group, or a trifluoroacetamido group, and R₂ can be a phenyl group or a phenylmethyl group. The second patent similarly describes an ester compound with the same properties and structural characteristics, emphasizing its potential in cancer treatment.
Career Highlights
Hiroaki Okuno is affiliated with the Agency of Industrial Science and Technology, where he continues to advance research in the field of cancer therapeutics. His innovative approach to drug design has garnered attention in the scientific community.
Collaborations
Okuno has collaborated with esteemed colleagues such as Yoshimitsu Yamazaki and Yoshikatsu Ogawa. Their combined expertise has contributed to the successful development of new therapeutic agents.
Conclusion
Hiroaki Okuno's contributions to the field of medicinal chemistry, particularly in anticancer agents, highlight his innovative spirit and dedication to improving cancer treatment. His patents reflect a commitment to advancing science for the benefit of patients worldwide.